CLINICAL AND PHARMACOKINETIC EVALUATION OF THE NEW BISNAPHTALAMIDE LU-79553 ADMINISTERED EVERY 21 DAYS IN PATIENTS WITH SOLID TUMORS - AN EORTC ECSG STUDY/
R. Thodtmann et al., CLINICAL AND PHARMACOKINETIC EVALUATION OF THE NEW BISNAPHTALAMIDE LU-79553 ADMINISTERED EVERY 21 DAYS IN PATIENTS WITH SOLID TUMORS - AN EORTC ECSG STUDY/, European journal of cancer, 33, 1997, pp. 1106-1106